Data / Form D filings / CryOSA, Inc.
CryOSA, Inc.: Form D filings
CryOSA, Inc., a biotechnology company in Arden Hills, MN, filed 2 Form D notices with the SEC between 2018 and 2025. The latest, on August 1, 2025, reports $6 million sold of a $15 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1265 Grey Fox Rd., Suite 5, Arden Hills, MN, 55112
- Phone
- (612) 489-5909
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1739698
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | New notice | $15,000,000 | $5,990,056 | $9,009,944 | 20 | Jun 30, 2025 | sec.gov |
| May 8, 2018 | New notice | $5,000,000 | $997,333 | $4,002,667 | 6 | Apr 25, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Doug French | Director | |
| James Eadie | Director | |
| Donald Gonzales | Director | |
| David Belitz | Director | |
| Laura Stoltenberg | Executive Officer, Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Jul 28, 2025 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CryOSA, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.